Related Experiment Video
Updated: Jul 9, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
New interventions in asthma including bronchial thermoplasty
1McMaster University, Ontario, Hamilton, Canada. coxp@mcmaster.ca
Current Opinion in Pulmonary Medicine
|November 29, 2007
Summary
Personalized asthma treatment is advancing with new therapies like antibiotics and bronchial thermoplasty. Noninvasive measurements help tailor treatments by defining individual asthma phenotypes and mechanisms.
Area of Science:
- Pulmonology
- Immunology
- Pharmacology
Background:
- Asthma is a complex respiratory condition with diverse underlying mechanisms.
- Current asthma management relies on broad-acting therapies like bronchodilators and corticosteroids.
Purpose of the Study:
- To review novel asthma therapies including antibiotics and bronchial thermoplasty.
- To highlight the role of noninvasive measurements in personalizing asthma treatment.
Main Methods:
- Phenotyping asthma patients using physiological and inflammatory markers.
- Utilizing measurements such as bronchial provocation, exhaled nitric oxide, and sputum cell analysis.
- Evaluating the efficacy of targeted therapies based on individual disease profiles.
Main Results:
- Asthma exhibits significant heterogeneity, necessitating individualized treatment approaches.
- Detailed phenotyping reveals specific disease mechanisms, guiding therapy selection.
- Novel therapies, including targeted biologics and bronchial thermoplasty, show promise for specific patient subgroups.
Conclusions:
- Asthma treatment is shifting towards personalized medicine, moving beyond traditional approaches.
- Detailed patient phenotyping is crucial for customizing treatment and improving outcomes.
- Interventions targeting specific disease mechanisms, such as airway remodeling, represent the future of asthma management.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...